BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 17145807)

  • 21. Differential transcriptional regulation of CD161 and a novel gene, 197/15a, by IL-2, IL-15, and IL-12 in NK and T cells.
    Azzoni L; Zatsepina O; Abebe B; Bennett IM; Kanakaraj P; Perussia B
    J Immunol; 1998 Oct; 161(7):3493-500. PubMed ID: 9759869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diverse populations of T cells with NK cell receptors accumulate in the human intestine in health and in colorectal cancer.
    O'Keeffe J; Doherty DG; Kenna T; Sheahan K; O'Donoghue DP; Hyland JM; O'Farrelly C
    Eur J Immunol; 2004 Aug; 34(8):2110-9. PubMed ID: 15259008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel epitope of N-CAM defines precursors of human adherent NK cells.
    Li S; Xu J; Makarenkova VP; Tjandrawan T; Vakkila J; Reichert T; Gooding W; Lagenaur CF; Achim CL; Chambers WH; Herberman RB; Whiteside TL; Vujanovic NL
    J Leukoc Biol; 2004 Dec; 76(6):1187-99. PubMed ID: 15356097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural killer receptors on CD8 T cells and natural killer cells from different HLA-C phenotypes in melanoma patients.
    Campillo JA; Martínez-Escribano JA; Moya-Quiles MR; Marín LA; Muro M; Guerra N; Parrado A; Campos M; Frías JF; Minguela A; García-Alonso AM; Alvarez-López MR
    Clin Cancer Res; 2006 Aug; 12(16):4822-31. PubMed ID: 16914567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-localized ligation of CD3 and CD28 with systemic regulatory T-cell depletion induces potent innate and adaptive antitumor responses.
    Lee CH; Chiang YH; Chang SE; Chong CL; Cheng BM; Roffler SR
    Clin Cancer Res; 2009 Apr; 15(8):2756-66. PubMed ID: 19318495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The increase of CD57+ T cells in the peripheral blood and their impaired immune functions in patients with advanced gastric cancer.
    Chochi K; Ichikura T; Majima T; Kawabata T; Matsumoto A; Sugasawa H; Kawarabayashi N; Takayama E; Hiraide H; Seki S; Mochizuki H
    Oncol Rep; 2003; 10(5):1443-8. PubMed ID: 12883721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy.
    Bamias A; Koutsoukou V; Terpos E; Tsiatas ML; Liakos C; Tsitsilonis O; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Papatheodoridis G; Archimandritis A; Antsaklis A; Dimopoulos MA
    Gynecol Oncol; 2008 Feb; 108(2):421-7. PubMed ID: 18036640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of CD4+CD25high regulatory T-cells in tumor-draining lymph nodes in patients with gastric cancer.
    Kawaida H; Kono K; Takahashi A; Sugai H; Mimura K; Miyagawa N; Omata H; Ooi A; Fujii H
    J Surg Res; 2005 Mar; 124(1):151-7. PubMed ID: 15734494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD28 costimulation overcomes transforming growth factor-beta-mediated repression of proliferation of redirected human CD4+ and CD8+ T cells in an antitumor cell attack.
    Koehler H; Kofler D; Hombach A; Abken H
    Cancer Res; 2007 Mar; 67(5):2265-73. PubMed ID: 17332357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The frequency of regulatory CD3+CD8+CD28- CD25+ T lymphocytes in human peripheral blood increases with age.
    Simone R; Zicca A; Saverino D
    J Leukoc Biol; 2008 Dec; 84(6):1454-61. PubMed ID: 18780874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD137 enhances cytotoxicity of CD3(+)CD56(+) cells and their capacities to induce CD4(+) Th1 responses.
    Zhu BQ; Ju SW; Shu YQ
    Biomed Pharmacother; 2009 Aug; 63(7):509-16. PubMed ID: 19019623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation-induced expression of CD56 by T cells is associated with a reprogramming of cytolytic activity and cytokine secretion profile in vitro.
    Kelly-Rogers J; Madrigal-Estebas L; O'Connor T; Doherty DG
    Hum Immunol; 2006 Nov; 67(11):863-73. PubMed ID: 17145366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased CD4CD25+FOXP3+ regulatory T Cells in cancer patients from conversion of CD4+CD25- T cells through tumor-derived factors.
    Mao C; Wang S; Jiang Q; Tong J; Ma J; Yang M; Xu X; Qiu G; Shao Q; Li L; Xu H
    Onkologie; 2008 May; 31(5):243-8. PubMed ID: 18497513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions.
    Allez M; Tieng V; Nakazawa A; Treton X; Pacault V; Dulphy N; Caillat-Zucman S; Paul P; Gornet JM; Douay C; Ravet S; Tamouza R; Charron D; Lémann M; Mayer L; Toubert A
    Gastroenterology; 2007 Jun; 132(7):2346-58. PubMed ID: 17570210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of adjuvant hormone therapy and chemotherapy on the immune system analysed in the bone marrow of patients with breast cancer.
    Solomayer EF; Feuerer M; Bai L; Umansky V; Beckhove P; Meyberg GC; Bastert G; Schirrmacher V; Diel IJ
    Clin Cancer Res; 2003 Jan; 9(1):174-80. PubMed ID: 12538466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytokine-induced killer cells are terminally differentiated activated CD8 cytotoxic T-EMRA lymphocytes.
    Franceschetti M; Pievani A; Borleri G; Vago L; Fleischhauer K; Golay J; Introna M
    Exp Hematol; 2009 May; 37(5):616-628.e2. PubMed ID: 19375652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chagasic patients with indeterminate clinical form of the disease have high frequencies of circulating CD3+CD16-CD56+ natural killer T cells and CD4+CD25High regulatory T lymphocytes.
    Vitelli-Avelar DM; Sathler-Avelar R; Dias JC; Pascoal VP; Teixeira-Carvalho A; Lage PS; Elói-Santos SM; Corrêa-Oliveira R; Martins-Filho OA
    Scand J Immunol; 2005 Sep; 62(3):297-308. PubMed ID: 16179017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transgene-enforced co-stimulation of CD4+ T cells leads to enhanced and sustained anti-tumor effector functioning.
    Chang L; Chang WC; McNamara G; Aguilar B; Ostberg JR; Jensen MC
    Cytotherapy; 2007; 9(8):771-84. PubMed ID: 17917884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural killer cell receptor T-lymphocytes in normal and Helicobacter pylori-infected human gastric mucosa.
    O'Keeffe J; Gately CM; O'Donoghue Y; Zulquernain SA; Stevens FM; Moran AP
    Helicobacter; 2008 Dec; 13(6):500-5. PubMed ID: 19166415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of both CD8+ and CD4+ T-cell-mediated responses in colorectal cancer patients by colon antigen-1.
    Maccalli C; Di Cristanziano V; Fodale V; Corsi D; D'Agostino G; Petrangeli V; Laurenti L; Guida S; Mazzocchi A; Arienti F; Perrone MP; Castelli C; Rivoltini L; Zagonel V; Tartaglia M; Parmiani G; Belardelli F
    Clin Cancer Res; 2008 Nov; 14(22):7292-303. PubMed ID: 18974390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.